JOHN BERLANGA: Open Payments
NPI 1730701723 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 38 payments from 10 companies in 2025. Trend: 2023 $941 · 2024 $1,144 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 11 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $139 |
| Amgen Inc. | 5 | $110 |
| Corcept Therapeutics | 2 | $75 |
| Fresenius USA Marketing, Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Lilly USA, LLC | 1 | $29 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 1 | $13 |
Products named: Veltassa, Kerendia, KRYSTEXXA, Korlym, VELPHORO, JARDIANCE, LOKELMA, FARXIGA.
Industry payments across TX — which companies pay providers there.
